InflaRx (IFRX) Net Margin (QoQ) (2018 - 2026)
InflaRx (IFRX) Net Margin (QoQ) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 140.00 Bn | 132.14 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.31 Bn | 78.32 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.24 Bn | 60.06 Bn | 1.37 Bn |
| 4 | Moderna | 62.41 Bn | 57.27 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.25 Bn | 37.15 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.18 Bn | 27.88 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.93 Bn | 10.54 Bn | 668.28 Mn |
| 8 | Insmed | 27.55 Bn | 26.39 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.28 Bn | 26.44 Bn | - |
| 10 | InflaRx | 138.95 Mn | -45.30 Mn | 2.74 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 27,528.00 |
| Dec 31, 2025 | 5.15 Mn |
| Sep 30, 2025 | -1.49 Mn |
| Jun 30, 2025 | -1.35 Mn |
| Mar 31, 2025 | -2.32 Mn |
| Dec 31, 2024 | 1.42 Mn |
| Sep 30, 2024 | 20.37 Mn |
| Jun 30, 2024 | -19.10 Mn |
| Mar 31, 2024 | -2.68 Mn |
| Dec 31, 2023 | -2,734.00 |
| Sep 30, 2023 | -49,361.00 |
| Jun 30, 2023 | 22.38 Mn |
| Mar 31, 2023 | -23.02 Mn |
| Dec 31, 2022 | 565,203.00 |
| Sep 30, 2022 | 110,198.00 |
| Jun 30, 2022 | -143,710.00 |
| Mar 31, 2022 | -60.73 Mn |
| Dec 31, 2021 | 60.71 Mn |
| Sep 30, 2021 | 169,859.00 |
| Jun 30, 2021 | -4,023.00 |